Marijuana Sector News

0 855
marijuana stocks
 

Marijuana Stocks Could Fly If This Measure Gets Passed

 

U.S. Attorney General Jeff Sessions is reportedly trying to build support to go after companies that sell marijuana in states that have legalized the drug. However, while the executive branch contemplates fighting marijuana, the legislative branch is taking the opposite approach.

 

 


Click Here Now To Read Full Article


 

What To Know When Investing In Marijuana Stocks

 

 

Legal Marijuana is the fastest growing industry in the United States. In 2016, cannabis sales in North America went up 30% from 2015 to reach $6.7 billion.

And looking into the future with more states, Canada and countries around the world making their way toward legalization this already extraordinary speed of growth is actually set to pick up. Canada’s recent decision to legalize recreational cannabis by next summer is expected to create a $23 billion industry that could be bigger than beer and wine.

 

 


Click Here Now To Read Full Article


 

 

 

Working In The Marijuana Industry Is Tougher Than You Think

Those who work in the marijuana industry with in the United States were to ever come together, there would be more of you than there are massage therapists, bakers or other classic paths to the middle class.

 


Click Here Now To Read Full Article


 

0 1189
marijuana-stock
 

mCig Inc. (MCIG) Supply Division Sales Reach $100k in One Week

 

mCig Inc. ( OTCQB : MCIG ), a diversified company servicing the legal cannabis, hemp and CBD markets is pleased to announce that one of its division, the Cannabis Supply Division, completed $100K in sales during the last week of June.

 

 


Click Here Now To Read (MCIG) Release


InCaseYouMissedIt: Tetra Bio-Pharma (TBPMF) Strengthens its Position on Bringing Marijuana to Patients

 

Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (CSE:TBP) (TBP.CN) (CNSX:TBP) (TBPMF), today announced that it has strengthened its position on bringing marijuana to patients in the form of a prescription drug. Tetra has become a world leader in the field of cannabis drug development and its PPP001 dried cannabis drug was covered in the Global Pain Management Drugs Market analysis report published by Azoth Analytics in May 2017. According to this report, Tetra is the only company developing dried marijuana as a drug.

 



Click Here Now To Read Full (TBPMF) Release


 

 

Could These Marijuana Stocks Be The First To Hit $1 Billion

The marijuana industry is growing at a rapid pace, and investors have surely taken notice. Much more marijuana stocks have witnessed their valuations increase substantially, or maybe run even higher, over the trailing 12-month period.

 


Click Here Now To Read Full Article


0 1903
 

Las Vegas Prepares For Recreational Marijuana Sales

 

Powered by one of the world’s biggest tourism industries, Nevada is preparing to do the same on July 1. A May report published by Gov. Brian Sandoval’s task force on marijuana estimates that up to 63 percent of recreational buyers will be tourists.

 

 


Click Here Now To Read Full Article


 

Legal Marijuana Makes It Tough For Police To Take Advantage Of Your Rights

 

 

According to a report from the Stanford Open Policing Project, which analyzed more than 100 million traffic stops across 31 states, motorists of all races are as much as three times less likely to be stopped and searched where, thanks to legalization, marijuana is no longer available as an excuse.

 

 


Click Here Now To Read Full Article


 

 

 

InCaseYouMissedIt: Investing in Cannabis is a No-Brainer

A new bill was passed that would effectively end the prohibition on the use of medicinal cannabis. While it was certainly a happy occasion to note the bipartisan effort put in, it is also frustrating to most to still have the struggle behind legalization. To have the amount of pushback against legislation in favor of a plant that has the ability to help many, is asinine to the majority of the public’s opinion.

 


Click Here Now To Read Full Article


0 1635
 

Tetra Bio-Pharma Inc. (TBPMF) Expands Focus of Commercialization Activities

 

Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(TBP.CN)(CNSX:TBP)(TBPMF), announced Wednesday (6-28) that it will also commercialize novel cannabinoid based formulations for the treatment of pet conditions.

 

 


Click Here Now To Read (TBPMF) Release


Legislation Is Taking More Of An Interest In Marijuana Propositions

 

Marijuana-related legislation has received more support in Congress this year than ever before. In reference to a report from MassRoots, there are now more federal lawmakers backing marijuana bills, especially those seeking to remedy the banking problem for the marijuana industry, than in past sessions.

 



Click Here Now To Read Full Article


 

 

Innovative Marijuana Cultivation Techniques Are Progressing In Italy

Italy is becoming one of the most progressive countries in Europe for cannabis cultivation, production, and innovation. Or maybe it has always been.

Alongside olives, tomatoes and the world’s best lemons, Italy has been growing hemp and cannabis for hundreds of years as industrial crops. Cannabis was essential to Italy’s shipping industry, which it supplied with material to make ropes, rigging, and sails.

 


Click Here Now To Read Full Article


0 3691
marijuana stock

Among the many segments of the marijuana industry that marijuana stock traders pay attention to, CBD or cannabidiol has taken on a major role. This is not only for its biotech-based applications but also for its uses outside of the health sciences sector. And with the growth that the market is projected t to see, CBD companies are definitely in the spotlight for the foreseeable future.

One Marijuana Stock that has been attracting the attention of marijuana investors has been Potnetwork Holdings, Inc. (POTN).  Now don’t let the name fool you, this company, through its subsidiary First Capital Venture Co., owns Diamond CBD Inc.;

Over the last few months, POTN has been breaking barriers with its CBD brand while also hitting major milestones for the better part of the first half of the year.  What could be best of all is that 2017 may already have the stage set for a record setting period in POTN’s company history.

Big Growth Already In Play?

In May of this year (2017) the company announced that it had realized first quarter figures that exceeded expectation by over $100,000, for a total of $1,858,347.48. They also established a merchandising pipeline of 7,000 authorized retail vendors through its distribution channels, which puts Diamond CBD at approximately 10,000 stores in the United States.

If this wasn’t enough, POTN further catapulted off of this first quarter momentum by recognizing over $2million from April to mid-May with a pace set to outshine the first quarter figure by a relatively large margin. Even assuming this rate of revenue generation and accounting for zero growth or contraction in revenues, POTN could be an $11million company by year’s end. Again this is assuming the company holds this course and does about $1million in revenue per month.

Let’s compare just by Revenue Figures Alone From Most Recent Annual Filings:

√ Medical Marijuana, Inc. 

$8.00m (Annual, 2016) Market Cap: $264.7M

√ Rocky Mountain High Brands, Inc.

$1.08m (Annual, 2016)   Market Cap: $ 53.4M

√ mCig, Inc.  

$4.5m (Annual, 2017)  Market Cap: $ 70.0M

√ Axim Biotechnologies, Inc.

$0.047m (Annual, 2016) Market Cap: $551.4M

Now look at these figures, the multiples are astronomical compared to their market caps:

  • mCig trades at roughly 15.5 times revenue
  • Medical Marijuana Inc. trades at nearly 33 times revenue
  • Rocky Mountain trades over 49.4 times revenue
  • Axim is trading at an astronomical 11,732 times revenue!

Now look at the same situation for Potnetwork. We can look at the 2016 annual for apples to apples comparison but the real story comes when you consider that Diamond CBD is now its subsidiary (which we’ll get into in a moment).

√ Potnetwork Holding, Inc.     

$1.03m    (Annual, 2016)   Market Cap: $38.2M

Even with last year being a slower year for the company, which could be attributed to the company’s future outlook and its uncertainty, Potnetwork had only traded at roughly 4 times revenue.

Now, let’s take into account the company’s last few months of announcements. By the figures given, it’s assumed that as of the end of May, Potnetwork revenue was in the ballpark of roughly $3.86m on a conservative estimate based on Q1 revenue and May revenues of over $1million: first quarter 2017 revenue of $1,858,347.48, “over $1 Million in April,” and “over $1Million for May.”

Price Target Given: $0.25

Being that this will be the first time that Diamond’s operations will be under the POTN flag, we can look at a brief snapshot of the company, at least from a first half standpoint of this year.

Even by just assuming that this company sees zero growth ahead and an outstanding share count of even 600m, at current prices of roughly $0.08, POTN would be a $48m market cap company with revenues of roughly $3.86m; only 12 times revenue.

But so far this year, a “zero growth” scenario has not been the case at all. In fact, based on recent announcements, growth for the company has been very pronounced so far. This is most likely a big reason why analysts are finding that the valuation for POTN is low right now. SeeThru Equity initiated coverage on Potnnetwork Holdings and recently gave a price target of $0.25. Meanwhile, the company continues to hit the convention circuit to build attention around the investment side of Potnetwork & Diamond CBD’s company as well as the actual product side of the business through countless tradeshow appearances.

And just recently the company announced that it has sold 80,000 Chill gummies since taking to the roadshow circuit. And currently POTN is “re stocking” over a two-week period to re-up its inventory of this brand.

The takeaway? In our opinion, compared to other presumed “industry leaders,” POTN is still trading at a fraction of the revenue multiple that these other companies are. Additionally, based on announcements, it doesn’t appear that the company, with Diamond CBD, is closing the doors and stopping its revenue growth anytime soon. This could be one of the more, if not the most undervalued CBD stocks in the market right now and the fundamentals show rapid growth projected along the way.

 “We are ecstatic with our results. We have learned to set our expectations high. As a result of the timing of CBD’s growing popularity and the quality of our products, our products are consistently met with reseller and consumer enthusiasm resulting in continuous escalating sales.”

-Maria Gomez, Regional Vice President of Sales for Diamond CBD, Inc.

The opportunity for taking advantage of the growth that CBD is beginning to see could be important to take into consideration.  Figures estimate that the CBD market will grow to a $2.1 billion market in sales by 2020. That’s a 700% increase from 2016.

Think about this for a moment: POTN is already growing and is expecting to continue this growth for the year, according to several announcements already made during the last few months…this is all going to happen during a time where the CBD industry as a whole is also anticipating significant growth.

Having already come off of a banner quarter, we think that preliminary guidance from the company would suggest that this is something to be paying close attention to during the second half of 2017.

 


Pursuant to an agreement between MAPH and Potnetwork Holdings, Inc., we were hired for a period of 1 month from 6/1/2017 – 7/1/2017 to publicly disseminate information about (POTN) including on the Website and other media including Facebook and Twitter. We are being paid $21,000 (CASH) by Potnetwork Holdings, Inc. via First Capital Ventures, Inc. an affiliate company for or “ZERO” shares of restricted or unrestricted common shares. We own zero shares of (POTN) which we purchased in the open market.We may buy or sell additional shares of (POTN) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

0 1303
 

PotNetwork Holding, Inc. (POTN) Will Be Featured On A National Radio and Webcast Show

 

PotNetwork Holding, Inc. (OTC PINK: POTN) is pleased to announce that the Company will be featured on the long running business show, on 1470am South Florida and filmed live on AMP2.TV LIVE and also heard on www.wwnnradio.com on the Money Watch Network.

 

 


Click Here Now To Read (POTN) Release


 

How Important Is Your Budtender

 

 

Budtenders working in weed dispensaries have a lot of influence over their customers, especially those who aren’t sure what they need, want or are looking for. Thankfully, most budtenders are knowledgeable and very helpful. While many started off behind the counters when the industry was still operating in the so-called “legal gray” area, they have learned on, and off, the job.

 

 


Click Here Now To Read Full Article


 

 

 

Legal Marijuana Makes It Difficult For Law Enforcement To Search Your Vehicle

Drug policy experts often say that the health risks of marijuana use are relatively minor compared to the steep costs of marijuana enforcement: expensive policing, disrupted lives, violence, and even death.

Law enforcement agencies, however, have often been at the forefront of opposition to marijuana legalization. One reason is that the drug, with its pungent, long-lasting aroma, is relatively easy to detect in the course of a traffic stop or other routine interaction. It’s an ideal pretext for initiating a search that otherwise wouldn’t be justified — even if that search only turns up evidence of marijuana use and nothing more.

 


Click Here Now To Read Full Article


 

80,000 Chill Gummies Sold as a Result of Highly Productive PotNetwork Road Show

 

PotNetwork Holding, Inc. (OTC Pink: POTN) announced today that the Company’s subsidiary, Diamond CBD, has entirely sold out of its increasingly popular proprietary Chill Gummy line.

The past six months of trade show, expo, and convention attendance have demonstrated Management’s determined commitment to achieve strong results, yielding in product demand requiring significant expansion of its manufacturing operations. The Company’s Chill Gummy inventory is slated to be restocked within approximately two weeks.

 

 


Click Here Now To Read (POTN) Release


Investing in Cannabis is a No-Brainer

 

This past Thursday a new bill was passed that would effectively end the prohibition on the use of medicinal cannabis. While it was certainly a happy occasion to note the bipartisan effort put in, it is also frustrating to most to still have the struggle behind legalization. To have the amount of pushback against legislation in favor of a plant that has the ability to help many, is asinine to the majority of the public’s opinion.

 



Click Here Now To Read Full Article


 

 

How Florida’s Medical Marijuana Will Change Under Proposed Rules

Health officials in the state of Florida have issued new rules to be implemented within the state’s constitutional medical marijuana amendment.

The regulations that were shown to the public on Friday by the Department of Health use the same framework as a bill passed on June ninth by the State Legislature during a special session. Last month, the department showed an outline to the public where it would give a fifteen days notice before they decided to put into play any new rules with the public having three days to submit feedback.

 


Click Here Now To Read Full Article


0 1602


ADVANTIS CORPORATION (ADVT ) Connects At Industry Outreach Event

ADVANTIS CORPORATION ( OTC PINK : ADVT ) CEO, Christopher Swartz, attended the Coastal Pacific political action committee’s Southern California Outreach Dinner last Tuesday night. The event was a fundraiser to support cannabis legalization. Swartz was an invited guest of Speedweed CEO, AJ Gentile.


Click Here Now To Read (ADVT) Release


Hemp, Inc. (HEMP) Powers Up Milling Operation for Industrial Hemp Production

Hemp, Inc. ( OTC PINK : HEMP ) is pleased to announce today that the milling portion of its industrial hemp decorticator is now online for beta testing and debugging. The disconnect switch, which connects the power to feed the 200-horse power motor on the grinder, was the final piece executives were awaiting to power up the mill. With the disconnect switch now installed, the team has powered up its hemp mill to beta test and debug the equipment. So far, the team has encountered some small software communication issues, but according to David Schmitt, COO of Hemp, Inc.’s wholly owned subsidiary, Industrial Hemp Manufacturing, LLC, those types of issues are the norm for the milling machinery and were expected.


Click Here Now To Read (HEMP) Release


 


INDUSTRY UPDATE: Biotech and Marijuana

Although researchers are beginning to learn about the medical benefits associated with cannabis, they have not even scratched the surface. The cannabis industry is the fastest growing industry in the world. After spending several years researching cannabis and developing products, companies are just beginning to realize the fruits of their efforts.


Click Here Now To Read Full Article


 

0 756

Cannabis Science Releases the Chronic Pain CBIS Transdermal Patches to Meet the Overwhelming Demand from Self-Medicating Patients Worldwide as it Continues to Expands its California Dispensary Network

“The CBIS medicated adhesive transdermal patch is placed on the skin to deliver a specific dose of cannabinoid medications into the bloodstream. Self-medicating patients have been reporting promoted healing effects to specific injured areas of the body experiencing chronic pain. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch can provide a controlled release of the medication into the patient, usually through a porous membrane covering a reservoir of medication or body heat that melts thin layers of high potency cannabinoid formulations embedded in the adhesive; the medication slowly enters the bloodstream at the chronic pain spot and then penetrates the central nervous system delivering the pain relief reported by self-medicating patients,” said Dr. Allen Herman, Chief Medical Officer of Cannabis Science.

As well, CBIS continues to grow its distribution network in Los Angeles, California by adding Kush Factory as CBIS’ newest Spotlight Dispensary for the month of July 2017.

Kush Factory is the latest dispensary to join the Cannabis Science new product distribution network and has received most of the recently released CBIS products, including the previously sold-out CBIS Metered Dose Inhalers (MDI) and the existing line of extracted tinctures, pills, sprays, balms, suppositories, and creams along with the upcoming release of more targeted controlled delivery modules.

As Spotlight Dispensary of the Month of July 2017, Kush Factory will be the first dispensary to carry the highly anticipated Chronic Pain CBIS Transdermal Patches.

The Kush Factory
612 N Vermont,
Los Angeles, California 90004
323-219-2827
kushfactoryla@gmail.com

Please contact Kush Factory directly for ordering all CBIS products and delivery schedules.

The CBIS MDI’s continue to be highly sought after and the company is working to increase production to meet strong demand from patients. The CBIS Unisex Suppository Regimen Package consists of rectal suppositories, and is the first of three regimen packages including a separate female and male package for self-medicating patients who prefer alternate delivery methods that will be released by CBIS.

About Cannabis Science, Inc.

Cannabis Science, Inc. takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.

Forward-Looking Statement

 This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a ‘safe harbor’ for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company is detailed from time to time in the company’s reports filed with the Securities and Exchange Commission.

0 1413
 

mCig, Inc., (MCIG) to Manage and Staff Indoor Grow Facility in Las Vegas

mCig, Inc., ( OTCQB : MCIG ), a leading distributor of innovative products, technologies, and services for the global medical cannabis industry is pleased to announce that Grow Contractors (GC) has signed a management contract to staff and manage a 15,000 square foot indoor cultivation facility in Las Vegas, Nevada for R.H. Medical.


Click Here Now To Read (MCIG) Release


PotNetwork Holding, Inc. (POTN) With $1,098,448.00 in May Revenues

PotNetwork Holding, Inc. (OTC PINK: POTN) is pleased to announce that its wholly owned subsidiary, Diamond CBD, Inc., after reporting a string of record-breaking monthly revenues, reports once again that it has surpassed projections yet again as the result of heightening demand for its products.


Click Here Now To Read Full (POTN) Release


 

 

The Amazing Effects Of Cannabis On The Brain And Body

Marijuana is most commonly known as a combination of the dried buds found in the Cannabis Sativa plant. There are many ways of using the plant such as eating, vaporizing, smoking, brewed, and tons more, however the most common method remains smoking the plant in some sort of pipe-like device.


Click Here Now To Read Full Article


Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements